Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment

New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has...
https://ift.tt/eA8V8J
from NDTV News - Topstories https://ift.tt/2Rhj5P9